A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

Summary

The purpose of this study is to evaluate if DVS SR is safe and effective in the treatment of pain associated with fibromyalgia syndrome, and if so to identify the efficacious doses.

Timeline

Start

2008-06

Primary completion

2009-01

Completion

2009-01

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs DVS SR; p = 0.471; Adjusted mean -0.38 (95% CI -1.42 to 0.66); ANCOVA NCT00696787 ↗

Drugs

Indications